GlassScriptPhysician profile
Michael A Taormina
NPI 1629257787
$6,051.49
in general payments reported to CMS, 2019-2025
46 companies · $1,092 in 2025
The $1,092 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $665 · 2021: $858 · 2022: $775 · 2023: $924 · 2024: $993 · 2025: $1,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,992 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,992.27 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $528.45 | 2021-2025 | Qulipta |
| Emd Serono, INC. | $344.71 | 2019-2024 | Mavenclad |
| Biogen, INC. | $334.87 | 2020-2025 | Vumerity, Leqembi, Tysabri |
| Teva Pharmaceuticals USA, INC. | $333.61 | 2020-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ucb, INC. | $291.22 | 2020-2025 | Rystiggo, Briviact, Zilbrysq |
| Pfizer INC. | $282.94 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $226.75 | 2019-2022 | |
| Lilly USA, LLC | $224.45 | 2019-2024 | Emgality, Amyvid |
| Kyowa Kirin, INC. | $213.61 | 2020-2024 | Nourianz |
| Genentech USA, INC. | $196.87 | 2019-2024 | Ocrevus |
| Amgen INC. | $196.51 | 2019-2023 | Aimovig |
| Sk Life Science, INC. | $193.34 | 2021-2025 | |
| Eisai INC. | $174.72 | 2019-2025 | |
| Tg Therapeutics, INC. | $165.23 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $162.83 | 2023-2025 | Nuedexta, Rexulti |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Taormina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.